Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia. Translation [Internet]. 2023 Dec. 15 [cited 2026 Jul. 27];11(3). Available from: https://dev.openjournals.utoledo.edu/index.php/translation/article/view/836